Midas Pharma Gmbh

ACTIVE

Utländsk Adr - Foreign Addr, Swedenwww.midas-pharma.comPrivate251–500 employeesEstablished: 1988-01-01

Also known as:

midas pharma gruppe

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1988

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

100.0%

Trial Status Distribution

Completed

66.7%

Recruiting

33.3%

Clinical Trials

Trials sponsored by this organization (3)

A study comparing different dosage forms of midazolam and how they are taken up in the body.

Phase 1

Recruiting

Jun 202616 participants

Drug-drug-interaction Study of Ramipril, Amlodipine and Atorvastatin

Phase 1

Completed

interventional

Feb 201918 participants

Drug-drug-interaction Study of Candesartan, Amlodipine and Atorvastatin

Phase 1

Completed

interventional

Jan 201918 participants

Approvals

Approvals by Agency

EMA

European Medicines Agency

Approvals

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

Approvals

Recent Approvals

RANIVISIO 10 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADA

CIMA_AEMPS

2025-05-29

Epruvy (previously Ranibizumab Midas)

EMA

2024-09-19

RANIVISIO 10 MG/ML SOLUCION INYECTABLE

News

No news articles found

Back to Organizations